ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal

August 1, 2014

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

Duke Insiders Allege Intimidation By Administration

July 23, 2010